Product
Myreptic-N
1 clinical trial
1 indication
Indication
Kidney TransplantClinical trial
A Multicenter, Randomization, Open-label Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant RecipientsStatus: Not yet recruiting, Estimated PCD: 2025-09-01